Health ❯ Diabetes ❯ Type 2 Diabetes

GLP-1 Receptor Agonists

Eli Lilly Therapeutic Uses Insulin Regulation Medication Side Effects Weight Loss Treatments Liraglutide Cardiovascular Health Semaglutide and Tirzepatide

Real-World Study Finds Semaglutide and Tirzepatide Cut Cardiovascular Risk in Type 2 Diabetes

A Nature Medicine analysis of nearly one million U.S. insurance records reports measurable cardiovascular risk reductions in routine care.

GLP-1 Drugs Plus Healthy Habits Linked to Bigger Heart Risk Drop in Veterans With Type 2 Diabetes

Cue-Driven Eaters Lose More Weight on GLP-1 Drugs, Japanese Study Finds

Bariatric Surgery Outperforms GLP-1 Medicines Over 10 Years for Patients With Diabetes and Obesity